Related Experiment Video
Updated: Aug 15, 2026

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
Published on: September 28, 2016
[Cardiac ion channel disorders--diagnosis and treatment]
Kristina Hermann Haugaa1, Knut Erik Berge, Andreas Früh
1Hjertemedisinsk avdeling, Rikshospitalet, 0027 Oslo. kristina.haugaa@rikshospitalet.no
Background:
Inherited arrhythmogenic disorders are a group of genetically determined diseases characterised by ventricular tachyarrhythmias sometimes leading to sudden death. The molecular bases of these disorders are mutations in genes coding for various cardiac ion channels. The most common cardiac ion channel disease is the long QT syndrome. This syndrome is rare, but probably more common in Norway than previously expected. We have recently started genetic testing for cardiac ion channel disorders at Rikshospitalet University Hospital in Oslo. This review describes the current understanding of the etiology, prognosis and management of cardiac ion channel disorders, based on literature and our own clinical experience.
Interpretation:
Cardiac ion channel disorders may lead to sudden cardiac death. Prophylactic and life-saving therapies are available for many of these disorders. Therapy and risk stratification depend on the clinical presentation, the ECG pattern, and which gene is mutated. Genetic testing offers the opportunity to exclude individual family members as mutation carriers.
More Related Videos
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Mechanism of Cardiac Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Cardiomyopathy V: Interprofessional Care

